Pharmacom Labs | Tirzepatide 15mg (Jaros) | Compound Peptide Vial
Advanced Dual GIP/GLP-1 Receptor Research Compound
Pharmacom Labs Jaros (Tirzepatide) is an investigational peptide research compound studied for its dual receptor activity across GIP and GLP-1 pathways, widely referenced in laboratory research exploring metabolic regulation, insulin signalling, and energy homeostasis mechanisms.
Tirzepatide-based compounds are commonly investigated in scientific models focused on glucose metabolism, appetite regulation pathways, and multi-receptor endocrine signalling within controlled experimental environments.
Developed as a 15mg compound peptide vial, this formulation is designed for laboratory preparation and controlled research applications where dual incretin receptor activity and metabolic pathway analysis are of scientific interest.
Pharmacom Labs Jaros Tirzepatide 15mg Compound Peptide Vial
• Dual GIP/GLP-1 receptor research compound studied in metabolic signalling models
• Investigated in insulin response and glucose regulation research
• Of interest in appetite control and energy balance pathway studies
• Explored in multi-receptor endocrine signalling research environments
• 15mg vial format designed for laboratory preparation use
• High-purity investigational formulation from Pharmacom Labs
• Manufactured for stability, consistency, and research reliability
• Strictly intended for laboratory research use only
⚖️ DISCLAIMER
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPHRA) for human or animal use.
This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.
Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease.
